Pipeline
Improving Human Wellness Through Innovative Recombinant Protein Biotechnology
Rotavirus acute gastroenteritis vaccines
More than 250,000 children under 5 years of age die annually from rotavirus
Rotavirus Vaccine: Supply and Demand Update (2022, UNICEF)
Medical Unmet Needs
-
The major pathogen causing
Acute gastroenteritis & diarrheal
In infants & toddlers -
Highly contagious pathogen
Transmission by fewer than
100 of viral particles -
High viability
Stable at 53℃ & pH 3
Market Trends
-
Global market 1Market size : An estimated $2.4 B (2022)
- Rotateq & Rotarix : The revenue is about $1.2 B - New vaccines & unmet needs : $918 M2Introduction into National Immunization Program (NIP) in 118 countries
Product
Manufacturer
2017
2018
Rotateq
MSD
772 B₩
819 B₩
Rotarix
GSK
766 B₩
780 B₩
-
Domestic market2About 50 B₩ per year Introduction into NIP in 2023
Product
Price/dose
# of dose
Total price
Rotateq
₩ 100,000
3
₩ 300,000
Rotarix
₩ 120,000
2
₩ 240,000
Rotavirus Vaccine - Right Foundation TAA & PDA progress
RIGHT Foundation
A Public-Private Partnership funding agency established as a partnership between Government of Korea, Korean Life Science
Companies,and Bill & Melinda Gates Foundation to support global health R&D.
InThera INC CEO : Deog-Young Choi B-218, 11, Beobwon-ro 11-gil, Songpa-gu, Seoul, Republic of Korea TEL 82-02-6239-2570